SQ Innovation today announced that results of the SUBCUT HF II trial of its product Lasix® ONYU, will be presented at Heart Failure 2026, the annual congress of the Heart Failure Association (HFA) of ...
A Swedish randomized trial found that slow up-dosing peanut oral immunotherapy with a low maintenance dose helped 82% of ...
CoreTissue BioEngineering Inc. ("CTBE"), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture, CEO: Yoji Jokura, Ph.D.) announces that the safety evaluation in the safety cohort ...
In recent book, UChicago’s Nicole P. Marwell and Jennifer E. Mosley argue that the research method isn’t always the best tool ...
Total hip arthroplasty leads to the best outcomes in the treatment of moderate-to-severe hip osteoarthritis, according to a ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
The growing body of clinical evidence for RevitalVision supports the integration of perceptual learning into routine ...
Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...
Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...
While Africa accounts for roughly 25% of the global disease burden, its people are largely invisible in randomised controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results